Rosuvastatin Krka Filmuhúðuð tafla 10 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

rosuvastatin krka filmuhúðuð tafla 10 mg

krka sverige ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 10 mg

Rosuvastatin Krka Filmuhúðuð tafla 20 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

rosuvastatin krka filmuhúðuð tafla 20 mg

krka sverige ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 20 mg

Rosuvastatin Krka Filmuhúðuð tafla 5 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

rosuvastatin krka filmuhúðuð tafla 5 mg

krka sverige ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 5 mg

Rosuvastatin Xiromed Filmuhúðuð tafla 40 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

rosuvastatin xiromed filmuhúðuð tafla 40 mg

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 40 mg

Sandimmun Neoral Mixtúra, lausn 100 mg/ml Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

sandimmun neoral mixtúra, lausn 100 mg/ml

novartis healthcare a/s - ciclosporinum inn - mixtúra, lausn - 100 mg/ml

Sandimmun Neoral Mjúkt hylki 100 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

sandimmun neoral mjúkt hylki 100 mg

novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 100 mg

Sandimmun Neoral Mjúkt hylki 25 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

sandimmun neoral mjúkt hylki 25 mg

novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 25 mg

Sandimmun Neoral Mjúkt hylki 50 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

sandimmun neoral mjúkt hylki 50 mg

novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 50 mg

Zejula Európai Unió - izlandi - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - Æxlishemjandi lyf - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.